WKN: | 883297 |
ISIN: | US6404911066 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Neogen-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 05. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2010 | 4,19 | 7,88 | 88,07% |
2 | 2007 | 1,85 | 3,06 | 65,41% |
3 | 2009 | 2,74 | 4,19 | 52,92% |
4 | 2003 | 1,20 | 1,82 | 51,67% |
5 | 2012 | 5,92 | 8,67 | 46,45% |
6 | 2013 | 8,67 | 12,07 | 39,22% |
7 | 2015 | 15,17 | 19,92 | 31,31% |
8 | 2023 | 14,20 | 18,30 | 28,87% |
9 | 2014 | 12,07 | 15,17 | 25,68% |
10 | 2021 | 32,50 | 40,40 | 24,31% |
11 | 2019 | 23,90 | 29,00 | 21,34% |
12 | 2016 | 19,92 | 23,62 | 18,57% |
13 | 2020 | 29,00 | 32,50 | 12,07% |
14 | 2005 | 1,79 | 1,95 | 8,94% |
15 | 2017 | 23,62 | 25,72 | 8,89% |
16 | 2004 | 1,82 | 1,79 | -1,65% |
17 | 2006 | 1,95 | 1,85 | -5,13% |
18 | 2018 | 25,72 | 23,90 | -7,08% |
19 | 2008 | 3,06 | 2,74 | -10,46% |
20 | 2011 | 7,88 | 5,92 | -24,87% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2025 | 11,80 | 4,02 | -65,93% |
2 | 2022 | 40,40 | 14,20 | -64,85% |
3 | 2002 | 1,94 | 1,20 | -38,14% |
4 | 2024 | 18,30 | 11,80 | -35,52% |
5 | 2011 | 7,88 | 5,92 | -24,87% |
6 | 2008 | 3,06 | 2,74 | -10,46% |
7 | 2018 | 25,72 | 23,90 | -7,08% |
8 | 2006 | 1,95 | 1,85 | -5,13% |
9 | 2004 | 1,82 | 1,79 | -1,65% |
10 | 2017 | 23,62 | 25,72 | 8,89% |
11 | 2005 | 1,79 | 1,95 | 8,94% |
12 | 2020 | 29,00 | 32,50 | 12,07% |
13 | 2016 | 19,92 | 23,62 | 18,57% |
14 | 2019 | 23,90 | 29,00 | 21,34% |
15 | 2021 | 32,50 | 40,40 | 24,31% |
16 | 2014 | 12,07 | 15,17 | 25,68% |
17 | 2023 | 14,20 | 18,30 | 28,87% |
18 | 2015 | 15,17 | 19,92 | 31,31% |
19 | 2013 | 8,67 | 12,07 | 39,22% |
20 | 2012 | 5,92 | 8,67 | 46,45% |